Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease–2019 Treatments Available and Affordable

Value in Health(2020)10.1016/j.jval.2020.04.1824Source: DataRank Database

The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease–2019 Treatments Available and Affordable is a research paper published in Value in Health (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.19)OA: bronzeTopics (47)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Joshua Cohen ORCID,Peter J. Neumann ORCID,Stefano Bertozzi ORCID,Anthony Kinghorn ORCID,Steven Forsythe ORCID

Live enrichment

PubMed:33127012 PMC:PMC7241391 OpenAlex:https://openalex.org/W3027881040

Wellcome Trust

Grant: unidentified

unidentified

FWCI

0.19

Citation Percentile

0.6%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.valueinhealthjournal.com/article/S1098301520320490/pdf

publisherhttp://www.valueinhealthjournal.com/article/S1098301520320490/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1098301520320490?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1098301520320490?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jval.2020.04.1824

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPharmaceutical Economics and Policy03 medical and health sciences0302 clinical medicine

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 Drug TreatmentHumansPneumonia, ViralPublic HealthCoronavirusCoronavirus InfectionsRitonavirPandemicsLopinavir

Keywords

PacePandemicCoronavirus disease 2019 (COVID-19)Global healthBusinessEconomic impact analysisEconomic growthGuardianHealth careMedicinePolitical scienceDiseaseEconomicsGeographyInfectious disease (medical specialty)RitonavirSARS-CoV-2Health PolicyPneumonia, ViralPublic Health, Environmental and Occupational HealthCOVID-19LopinavirCOVID-19 Drug TreatmentCoronavirusBetacoronavirusThemed Section: COVID-19HumansPublic HealthCoronavirus InfectionsPandemics

Additional file 1 of The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis

10.6084/m9.figshare.26681752.v1figshare

Additional file 1 of The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis

10.6084/m9.figshare.26681752figshare